跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DIASTAT - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DIASTAT
Authorized
STANDARD
DIASTAT
bausch health, canada inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
1a4ef7969b1d45db
Company
bausch health, canada inc.
Type
Standard
Approval Details
Approval Id
1a4ef7969b1d45db
Drug Approval Canada Name
DIASTAT
Product Name
DIASTAT
Status
Marketed
Status Date
2022-04-21
Original Market Date
2022-04-21
Din
02519089
Drug Class
Human
Dosage Form
Gel
Route Of Administration
Rectal
Schedule
Targeted (CDSA IV)
Ahfs
28:24.08
Atc Original
N05BA01 DIAZEPAM
Atc Name
n 05 ba 01
Aig Number
0103614001
Company Name
bausch health, canada inc.
Company Address
2150 Boul. St-Elzear Ouest, Laval, Quebec, Canada, H7L 4A8
Active Ingredients
DIAZEPAM
15 MG / 3 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
1a4ef7969b1d45db
Type
Standard
Back to Health Canada Approvals